March 28, 2025 - 22:48

US stock futures slipped as Wall Street continues to grapple with President Trump's escalating trade war. The financial markets are experiencing significant volatility, with major indices such as the Dow Jones Industrial Average dropping by 700 points. This sharp decline reflects growing concerns over tariffs and inflation, which are causing uncertainty among investors.
The S&P 500 and Nasdaq also faced steep losses, contributing to a broader sense of unease in the market. Analysts point to the potential repercussions of the ongoing trade disputes, which could lead to increased costs for consumers and businesses alike. The fear of rising inflation is further exacerbating the situation, as higher prices could diminish consumer spending and economic growth.
As traders respond to these developments, many are closely monitoring government policies and potential resolutions to the trade conflict. The current climate poses challenges for investors, who are navigating a landscape marked by unpredictability and heightened risk.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...